These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 17167759)

  • 1. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
    Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
    Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphopenia associated with survivin and its downstream pathway in COVID-19 serving as a potential route in COVID-19 pathogenesis.
    Kahrizi MS; Nasiri K; Ebrahimzadeh F; Yaseri AF; Ghodratizadeh S; Gholamrezaei M; Rahat Dahmardeh A; Adili A; Amjidifar R; Hemmatzadeh M; Arabi M; Maghsoudi MR; Mohammadi H
    Adv Med Sci; 2024 Mar; 69(1):190-197. PubMed ID: 38521459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin, β-catenin, and ki-67 immunohistochemical expression in canine perivascular wall tumors: Preliminary assessment of prognostic significance.
    Godizzi F; Armando F; Boracchi P; Avallone G; Stefanello D; Ferrari R; Chiti LE; Cappelleri A; Zamboni C; Dell'Aere S; Corradi A; Roccabianca P
    Vet Pathol; 2024 May; ():3009858241246981. PubMed ID: 38727195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of quercetin and paclitaxel combination on ovarian cancer cells.
    Ji H; Zhang Z; Chen C; Xu W; Liu T; Dong Y; Wang J; Wang H; Zhu X
    iScience; 2024 Aug; 27(8):110434. PubMed ID: 39108714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analysis identifies BIRC5 as a prognostic biomarker.
    Fäldt Beding A; Larsson P; Helou K; Einbeigi Z; Parris TZ
    BMC Cancer; 2022 Mar; 22(1):322. PubMed ID: 35331169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis.
    Gąsowska-Bajger B; Gąsowska-Bodnar A; Knapp P; Bodnar L
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33669912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death.
    Thibault B; Genre L; Le Naour A; Broca C; Mery E; Vuagniaux G; Delord JP; Wiedemann N; Couderc B
    Sci Rep; 2018 Dec; 8(1):17862. PubMed ID: 30552344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients.
    Li S; Wang L; Meng Y; Chang Y; Xu J; Zhang Q
    Oncotarget; 2017 Jun; 8(25):41282-41293. PubMed ID: 28476037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP.
    Li X; Chen W; Zeng W; Wan C; Duan S; Jiang S
    Br J Cancer; 2017 Jan; 116(1):66-76. PubMed ID: 27875524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XIAP RING domain mediates miR-4295 expression and subsequently inhibiting p63α protein translation and promoting transformation of bladder epithelial cells.
    Jin H; Xu J; Guo X; Huang H; Li J; Peng M; Zhu J; Tian Z; Wu XR; Tang MS; Huang C
    Oncotarget; 2016 Aug; 7(35):56540-56557. PubMed ID: 27447744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin and cycline D1 expressions are associated with malignant potential in mucinous ovarian neoplasms.
    Kanter M; Turan G; Usta C; Usta A; Esen HH; Tavlı L; Celik C; Demirkol Y; Kanter B
    J Mol Histol; 2016 Apr; 47(2):145-52. PubMed ID: 26815661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer.
    Du J; Li B; Fang Y; Liu Y; Wang Y; Li J; Zhou W; Wang X
    BMC Cancer; 2015 Jul; 15():536. PubMed ID: 26198101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma.
    Davidson B; Nymoen DA; Elgaaen BV; Staff AC; Tropé CG; Kærn J; Reich R; Falkenthal TE
    Virchows Arch; 2014 Jun; 464(6):701-7. PubMed ID: 24756216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Txr1: an important factor in oxaliplatin resistance in gastric cancer.
    Bi J; Bai Z; Ma X; Song J; Guo Y; Zhao J; Yi X; Han S; Zhang Z
    Med Oncol; 2014 Feb; 31(2):807. PubMed ID: 24362794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies.
    Le Page C; Huntsman DG; Provencher DM; Mes-Masson AM
    Cancers (Basel); 2010 May; 2(2):913-54. PubMed ID: 24281100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sandwich ELISA for detecting urinary Survivin in bladder cancer.
    Li X; Wang Y; Xu J; Zhang Q
    Chin J Cancer Res; 2013 Aug; 25(4):375-81. PubMed ID: 23997523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
    Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
    Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migfilin, α-parvin and β-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases.
    Davidson B; Holth A; Nguyen MT; Tropé CG; Wu C
    Gynecol Oncol; 2013 Feb; 128(2):364-70. PubMed ID: 23099104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZNF385B and VEGFA are strongly differentially expressed in serous ovarian carcinomas and correlate with survival.
    Elgaaen BV; Olstad OK; Sandvik L; Odegaard E; Sauer T; Staff AC; Gautvik KM
    PLoS One; 2012; 7(9):e46317. PubMed ID: 23029477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion.
    Li J; Li ZN; Bao QL; Ge LP; Li XQ; Chen P
    Tumour Biol; 2012 Oct; 33(5):1803-10. PubMed ID: 22696161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.